Primary vaccination and revaccination of young adults with BCG: A study using immunological markers

References

• Clements CJ. Vaccination: the current status of BCG. Mycobacteria and TB. Karger, SHE Kaufmann, H Hahn, 2003; 46–66
   Google Scholar
• Springett VH, Sutherland I. A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trials. Tuber Lung Dis 1994; 75: 227–33
   PubMedGoogle Scholar
• Kubit S, Czajka S, Olakowski T, Piasecki Z. Effectiveness of BCG vaccination. Pediatr Pol 1983; 58: 775–81
   PubMedGoogle Scholar
• Tala-Heikkila MM, Tuominen JE, Tala EO. Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence. Am J Respir Crit Care Med 1998; 157: 1324–7
   PubMed Web of Science ®Google Scholar
• Barbosa T, Arruda S, Fernandes BD, Carvalho LP, Cardoso S, Cunha S, et al. BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children. Vaccine 2003; 21: 2152–60
   PubMed Web of Science ®Google Scholar
• Nabeshima S, Murata M, Yamaji K, Chong Y, Nomoto M, Hayashi J. Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination. J Infect Chemother 2005; 11: 18–23
   PubMedGoogle Scholar
• Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomized trial. Lancet 2005; 366: 1290–5
   PubMed Web of Science ®Google Scholar
• Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, et al. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guerin vaccination. J Lab Clin Med 1999; 134: 244–52
   PubMedGoogle Scholar
• Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomized controlled studies. Lancet 2002; 359: 1393–1401
   PubMed Web of Science ®Google Scholar
• Weir RE, Black GF, Nazareth B, Floyd S, Stenson S, Stanley C, et al. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to Bacille Calmette-Guerin vaccination in southern England and northern Malawi. Clin Exp Immunol 2006; 146: 390–9
   PubMed Web of Science ®Google Scholar
• Ravn P, Boesen H, Klarlund Pedersen B, Andersen P. Human T-cell responses induced by vaccination with Mycobacterium bovis Bacille Calmette-Guérin. J Immunol 1997; 158: 1949–55
   PubMed Web of Science ®Google Scholar
• Flynn JF. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004; 84: 93–101
   PubMed Web of Science ®Google Scholar
• Barnes P, Vankayalapati R. Th1 and Th2 cytokines in the human immune response to tuberculosis. Tuberculosis and the tubercle bacillus, ST Cole, KD Eisenach, DN McMurray, WRJ Jacobs. ASM press, Washington, DC 2005; 489–96
   Google Scholar
• Leal IS, Florido M, Andersen P, Appelberg R. Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine. Immunology 2001; 103: 375–81
   PubMedGoogle Scholar
• De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10: 133–9
   PubMedGoogle Scholar
• Hoft DF, Worku S, Kampmann B, Whalen CC, Ellner JJ, Hirsch CS, et al. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis 2002; 186: 1448–57
   PubMed Web of Science ®Google Scholar
• Mawa PA, Pickering JM, Miiro G, Namujju PB, Watera C, Anyaegani G, et al. The effect of tuberculin skin testing on viral load and anti-mycobacterial immune responses in HIV-1-infected Ugandan adults. Int J Tuberc Lung Dis 2004; 8: 586–92
   PubMedGoogle Scholar
• Rosenthal SR. Resistance to tuberculosis in man. BCG vaccine: tuberculosis-cancer, SR Rosenthal. PSG Publishing Company, Littleton, Massachusetts 1980; 220–52
   Google Scholar
• Greenberg PD, Lax KG, Schechter CB. A decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis 1991; 143: 490–5
   PubMedGoogle Scholar
• Bloom, BR, Fine, PEM. The BCG experience: implication for future vaccines against tuberculosis. In:. BR Bloom. Tuberculosis pathogenesis protection and control. Washington, DC: ASM Press; 1994. p. 531–57.
   Google Scholar
• Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366: 1443–51
   PubMed Web of Science ®Google Scholar
• Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003; 133: 30–7
   PubMed Web of Science ®Google Scholar
• Brudey K, Gordon M, Moström P, Svensson L, Jonsson B, Sola C, et al. Molecular epidemiology of Mycobacterium tuberculosis in western Sweden. J Clin Microbiol 2004; 42: 3046–51
   PubMedGoogle Scholar
• Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination?. Int J Tuberc Lung Dis 1998; 2: 200–7
   PubMed Web of Science ®Google Scholar
• Cheon SH, Kampmann B, Hise AG, Phillips M, Song HY, Landen K, et al. Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin Diagn Lab Immunol 2002; 9: 901–7
   PubMedGoogle Scholar
• Cunha AJ, Sant'Anna CC, Mannarino R, Labanca TC, Ferreira S, March MF. Adverse effects of BCG revaccination: a report on 13 cases from Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2002; 6: 1110–3
   PubMed Web of Science ®Google Scholar
• Arantes GR. Post-vaccinal tuberculin sensitivity and its irrelevance to BCG revaccination. Rev Saude Publica 1980; 14: 234–45
   PubMedGoogle Scholar